Patent - Abbreviated New Drug Application Cases
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al.
as 2:2018cv09347
Plaintiff: IMPAX LABORATORIES, INC.
Defendant: ACTAVIS LABORATORIES FL, INC. and ACTAVIS PHARMA INC.
Cause Of Action: 35 U.S.C. § 271
Shire Development LLC et al v. Impax Laboratories, Inc.
as 1:2018cv00549
Plaintiff: Shire Development LLC , Shire LLC and Shire US Inc.
Defendant: Impax Laboratories, Inc.
Counter_claimant: Impax Laboratories, Inc.
Counter_defendant: Shire Development LLC , Shire LLC and Shire US Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH v. IMPAX Laboratories, Inc.
as 1:2018cv00350
Plaintiff: Biogen International GmbH
Defendant: IMPAX Laboratories, Inc.
Counter_claimant: IMPAX Laboratories, Inc.
Counter_defendant: Biogen International GmbH
Cause Of Action: 35 U.S.C. § 271
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al We have downloadable decisions or orders for this case
as 2:2017cv13476
Plaintiff: IMPAX LABORATORIES, INC.
Defendant: ZYDUS PHARMACEUTICALS USA, INC. and CADILA HEALTHCARE LTD.
Cause Of Action: 15 U.S.C. § 1126
Biogen MA Inc. v. Impax Laboratories, Inc.
as 1:2017cv00826
Plaintiff: Biogen MA Inc.
Defendant: IMPAX Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al. We have downloadable decisions or orders for this case
as 1:2017cv00823
Defendant: TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff: Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?